• No results found

Acknowledgements

During my time as a PhD student I have been fortunate to meet many inspiring people to whom I am very thankful. I would like to express my sincere gratitude to all my friends and co-workers who have encouraged me on this journey!

My sincere and deepest gratitude to:

All the patients and controls who made this project possible.

Britta Hylander, PhD, Associate Professor, Department of Nephrology, for being the greatest supervisor. Thank you for believing in me and my wild ideas. You have encouraged me in new projects and helped me to achieve my goals in science, and done endless proofreading with

invaluable co-writing. Also thank you for your never-ending enthusiasm and for guiding me. What a great friend!

Carl-Gustaf Elinder, Professor, Head of Department of Nephrology, for support, proofreading manuscripts, and guidance.

Stefan Jacobson, Professor, Former Head of Department of Nephrology, for all support and help.

Ingrid Nicander, PhD, DDS, my colleague and co-supervisor, for your great interest in my project, and guidance in the impedance research field.

Stephan Rössner, Professor, Karolinska Institutet, for sharing your

knowledge, proofreading papers, and being the source of great laughs. You are an inspiration both in science and in the kitchen.

Martin Neovius, PhD, Karolinska Institutet, co-writer and provider of help with statistics. Your enthusiasm and shared knowledge gave me strength to forge ahead.

Joachim Lundahl, Professor, Head of Department, co-writer, for the positive and inspiring conversation in the field of inflammation.

Tulay Lindberg, Associate Professor, Karolinska Institutet, Faculty of Odontology, Department of Dental Medicine, co-writer and invaluable support in understanding analysis of samples at the Department of Dental Medicine, Karolinska Institutet.

Keith Eliasson, PhD, MD for all support and proofreading.

Lennart Möller, Professor and co-writer, Head of the Department of Nutrition and Biosciences, Karolinska Institutet, for inspiring discussions and interest in my project.

Clara Johansson and Ylva Rodhe, ME, PhD students, co-writers and invaluable analysis work. Thank you for inspiring discussions and patience with a dentist.

Leif Jansson, PhD, DDS, Specialist in Periodontology, Head of

Department at the Periodontal Clinic, Folktandvården Stockholms Läns Landsting AB and colleague, for interesting discussions and comments on my work.

Helena Thålin, Head of Department at Folktandvården Sollentuna, valued colleague and great travel companion, and her staff, for providing crucial support with controls from the clinic’s patient list.

Kristina Burendahl, Head of Department at Folktandvården Solna, valued colleague, and her staff for providing crucial support with controls from the clinic’s patient list and clinic facilities.

Harald Abelin, Former CEO of Folktandvården Stockholms Läns Landsting AB, for inspiring conversations and trust in the project.

Folktandvården Stockholm Läns Landsting AB, Executive Board, for trust in the project and financial support.

Inger Wårdh, PhD, DDS Karolinska Institutet, valued colleague and friend, for inspiring conversation about science, our field of research and the future.

Gunilla Nordenram, PhD, DDS, Karolinska Institutet, Faculty of

Odontology, valued colleague and friend, for interesting lunches and great laughs.

Åsa Markusson, Ulla Berggren, Rosangela De Souza Silva Hallin, Dental Nurses,

Department of Dental Medicine, for great support and assistance. And for great laughs and wonderful senses of humor.

Christine Olsbro, Registered Nurse, Department of Nephrology, Karolinska University Hospital, for helping out with patients and providing efficient blood tests and laboratory routines over the years.

Irene Paul, Gun Löndahl, Registered Nurses, Department of Nephrology.

Rosie Åkers and Anette Bygdén, Nurses at the Department of Nephrology, for all help with patients, blood samples, and laboratory work.

Nina Jansson-Broström, Assistant, for all support and help with the patients at the hemodialysis unit.

All doctors and staff in the Department of Nephrology at Karolinska University Hospital.

Ingela Fehrman, Professor, Sophiahemmet and staff, for kind and generous support in one clinical study.

Staff at the Kronan dialysis units, Kungsholmsdialysen, and Löwenströmska Hospital, for kind support and help in the clinical studies.

Family and friends for great laughs and bringing me down to earth, making it clear where my roots are and what is important in life. For sharing life and joy with me.

Emma and Johannes, my dear children. You light up my life and make it all worth fighting for.

And finally, Stina, my wonderful wife! Thank you for believing in me and encouraging me, for being my lifetime companion, for sharing laughs and sorrows. You are the best!

.

This project was supported by grants from The National Kidney Association - Svensk Njurmedicinsk förening, The Swedish Kidney Association - Njursjukas Riksförening, Scandinavian Clinical Nutrition and Scibase.

13 REFERENCES

1. Buhlin K, Barany P, Heimburger O, Stenvinkel P, Gustafsson A.

Oral health and pro-inflammatory status in end-stage renal disease patients. Oral Health Prev Dent 2007;5:235-44.

2. James TJ, Lewis AV, Tan GD, Altmann P, Taylor RP, Levy JC.

Validity of simplified protocols to estimate glomerular filtration rate using iohexol clearance. Ann Clin Biochem 2007 Jul;44(Pt 4):369-76.

3. Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J. Are there two types of malnutrition in chronic renal failure?

Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrology Dialysis

Transplantation 2000 Jul;15(7):953-60.

4. Hugoson A, Koch G, Gothberg C, Helkimo AN, Lundin SA, Norderyd O, et al. Oral health of individuals aged 3-80 years in Jonkoping, Sweden during 30 years (1973-2003). II. Review of clinical and radiographic findings. Swed Dent J 2005;29(4):139-55.

5. Hugoson A, Norderyd O, Slotte C, Thorstensson H. Oral hygiene and gingivitis in a Swedish adult population 1973, 1983 and 1993.

Journal of Clinical Periodontology 1998 Oct;25(10):807-12.

6. Sobrado Marinho JS, Tomas Carmona I, Loureiro A, Limeres Posse J, Garcia Caballero L, Diz Dios P. Oral health status in patients with moderate-severe and terminal renal failure. Medicina Oral, Patologia Oral y Cirugia Bucal 2007;12(4):E305-10.

7. Flink H, Bergdahl M, Tegelberg A, Rosenblad A, Lagerlof F.

Prevalence of hyposalivation in relation to general health, body mass index and remaining teeth in different age groups of adults.

Community Dentistry & Oral Epidemiology 2008 Dec;36(6):523-8. 31. von Bultzingslowen I, Sollecito TP, Fox PC, Daniels T, Jonsson R,

Lockhart PB, et al. Salivary dysfunction associated with systemic diseases: systematic review and clinical management

recommendations. Oral Surgery Oral Medicine Oral Pathology Oral Radiology & Endodontics 2007;103 Suppl:S57 e1-15.

9. Tomas I, Marinho JS, Limeres J, Santos MJ, Araujo L, Diz P.

Changes in salivary composition in patients with renal failure.

Archives of Oral Biology 2008 Jun;53:528-32.

10. Javed F, Nasstrom K, Benchimol D, Altamash M, Klinge B,

Engstrom PE. Comparison of periodontal and socioeconomic status between subjects with type 2 diabetes mellitus and non-diabetic controls. Journal of Periodontology 2007 Nov;78(11):2112-9.

11. Kshirsagar Aea. Periodontal disease adversely affects the survival of patients with end-stage renal disease. Kidney International 2009;Jan 21(Epub ahead of print).

12. Antoniades DZ, Markopoulos AK, Andreadis D, Balaskas I, Patrikalou E, Grekas D. Ulcerative uremic stomatitis associated with untreated chronic renal failure: report of a case and review of the literature. Oral Surgery Oral Medicine Oral Pathology Oral Radiology & Endodontics 2006 May;101(5):608-13.

13. Shoham DA, Vupputuri S, Kaufman JS, Kshirsagar AV, Diez Roux AV, Coresh J, et al. Kidney disease and the cumulative burden of life course socioeconomic conditions: the

Atherosclerosis Risk in Communities (ARIC) study. Soc Sci Med 2008 Oct;67(8):1311-20.

14. Roth JM, Restani RG, Goncalves TT, Sphor SL, Ness AB, Martino-Roth MG, et al. Genotoxicity evaluation in chronic renal patients undergoing hemodialysis and peritoneal dialysis, using the

15. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney International 2002 Nov;62(5):1524-38.

16. Izutsu K. Theory and measurement of the buffer value of bicarbonate in saliva. J Theor Biol 1981;90:397.

17. Cardoso EM AA, Tumilasci OR, Elbert A, Contreras LN.

Assessment of salivary urea as a less invasive alternative to serum determinations. Scand J Clin Lab Invest 2008;Nov(21):1-5.

18. Wotman S MI, Thompson RH Jr, Laragh JH. Salivary elecrolytes, urea, nitrogen, uric acid and salt taste thresholds in hypertension. J Oral Ther Pharmacol 1967;3:237.

19. Ben-Aryeh H SM, Shasha S, Szargel R, Gutman D. Salivary composition in patients with essential hypertension and the effect of pindolol. J Oral Med 1981;36:76.

20. van Hooff M vBM, Schools M, Rahn KH. Studies of salivary flow in borderline hypertension: effects of drugs acting on structures innervated on the autonomic nervous system. Clin Sci

1984;66:599.

21. Zachara BA, Gromadzinska J, Wasowicz W, Zbrog Z. Red blood cell and plasma glutathione peroxidase activities and selenium concentration in patients with chronic kidney disease: a review.

Acta Biochim Pol 2006;53(4):663-77.

22. Sener G, Sakarcan A, Sehirli O, Eksioglu-Demiralp E, Sener E, Ercan F, et al. Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast. Prostaglandins Other Lipid Mediat 2007

Jun;83(4):257-67.

23. Stenvinkel P, Alvestrand A. Inflammation in end-stage renal disease: sources, consequences, and therapy. Seminars in Dialysis 2002;15:329-37.

24. Stenvinkel P. Inflammatory and atherosclerotic interactions in the depleted uremic patient. Blood Purification 2001;19:53-61.

25. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney International 1999;55:1899-911.

26. Vaziri ND. Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol 2004 Sep;24(5):469-73.

27. Bibi G, Green Y, Nagler RM. Compositional and oxidative analysis in the saliva and serum of predialysis chronic kidney disease patients and end-stage renal failure patients on peritoneal dialysis. Therap Apher Dial 2008 Apr;12(2):164-70.

28. Kalantar-Zadeh K, Balakrishnan VS. The kidney disease wasting:

inflammation, oxidative stress, and diet-gene interaction.

Hemodialysis International 2006;10:315-25.

29. Kalantar-Zadeh K. The latest addition to the inflammatory homeboys in chronic kidney disease: interleukin-8.[comment].

Nephron 2006;102:c59-60.

30. WHO. Oral health surveys. Basic methods. Fourth edition. 1997.

31. Chisholm DM, Mason DK. Salivary gland disease. Br Med Bull 1975 May;31:156-8.

32. Ericsson Y HL. Individual diagnosis, prognosis and counselling for caries prevention. Caries Res 1978;12(Suppl. 1):94.

33. Eliasson L, Birkhed D, Osterberg T, Carlen A. Minor salivary gland secretion rates and immunoglobulin A in adults and the elderly. European Journal of Oral Sciences 2006 Dec;114(6):494-34. 9. Bayraktar G, Kurtulus I, Duraduryan A, Cintan S, Kazancioglu R,

Yildiz A, et al. Dental and periodontal findings in hemodialysis patients. Oral Diseases 2007;13(4):393-7.

35. Bots CP, Poorterman JH, Brand HS, Kalsbeek H, van Amerongen BM, Veerman EC, et al. The oral health status of dentate patients with chronic renal failure undergoing dialysis therapy. Oral Diseases 2006;12(2):176-80.

36. Vesterinen M, Ruokonen H, Leivo T, Honkanen AM, Honkanen E, Kari K, et al. Oral health and dental treatment of patients with renal disease. Quintessence International 2007;38(3):211-9.

37. Klassen JT, Krasko BM. The dental health status of dialysis patients. Journal of the Canadian Dental Association

2002;68(1):34-8.

38. Frankenthal S, Nakhoul F, Machtei EE, Green J, Ardekian L, Laufer D, et al. The effect of secondary hyperparathyroidism and hemodialysis therapy on alveolar bone and periodontium. Journal of Clinical Periodontology 2002;29(6):479-83.

39. Gavalda C, Bagan J, Scully C, Silvestre F, Milian M, Jimenez Y.

Renal hemodialysis patients: oral, salivary, dental and periodontal findings in 105 adult cases. Oral Diseases 1999;5(4):299-302.

40. Kshirsagar AV, Craig RG, Beck JD, Moss K, Offenbacher S, Kotanko P, et al. Severe periodontitis is associated with low serum albumin among patients on maintenance hemodialysis therapy.

Clinical Journal of The American Society of Nephrology: CJASN 2007;2(2):239-44.

41. Cesar-Neto JB, Duarte PM, de Oliveira MC, Casati MZ, Tambeli CH, Parada CA, et al. Smoking modulates interferon-gamma expression in the gingival tissue of patients with chronic periodontitis. European Journal of Oral Sciences 2006 Oct;114(5):403-8.

42. Osterberg T, Mellstrom D. Tobacco smoking: a major risk factor for loss of teeth in three 70-year-old cohorts. Community Dentistry

& Oral Epidemiology 1986 Dec;14(6):367-70.

43. Nibali L, Griffiths GS, Donos N, Parkar M, D'Aiuto F, Tonetti MS, et al. Association between interleukin-6 promoter haplotypes and aggressive periodontitis. Journal of Clinical Periodontology 2008 Mar;35(3):193-8.

44. Borawski J, Wilczynska-Borawska M, Stokowska W, Mysliwiec M. The periodontal status of pre-dialysis chronic kidney disease and maintenance dialysis patients.[see comment]. Nephrology Dialysis Transplantation 2007;22(2):457-64.

45. Bots CP, Brand HS, Poorterman JH, van Amerongen BM,

Valentijn-Benz M, Veerman EC, et al. Oral and salivary changes in patients with end stage renal disease (ESRD): a two year follow-up study. British Dental Journal 2007;202(2):E3.

46. Summers SA, Tilakaratne WM, Fortune F, Ashman N. Renal disease and the mouth. American Journal of Medicine

2007;120(7):568-73.

47. Fored CM, Ejerblad E, Fryzek JP, Lambe M, Lindblad P, Nyren O, et al. Socio-economic status and chronic renal failure: a population-based case-control study in Sweden. Nephrology Dialysis

Transplantation 2003 Jan;18(1):82-8.

48. Naugle K, Darby ML, Bauman DB, Lineberger LT, Powers R. The oral health status of individuals on renal dialysis. Annals of

Periodontology 1998;3(1):197-205.

49. Salonen L, Axell T, Hellden L. Occurrence of oral mucosal lesions, the influence of tobacco habits and an estimate of treatment time in an adult Swedish population. Journal of Oral Pathology &

Medicine 1990;19(4):170-6.

50. Tapper-Jones LM, Aldred MJ, Walker DM, Hayes TM. Candidal infections and populations of Candida albicans in mouths of diabetics. Journal of Clinical Pathology 1981;34(7):706-11.

51. Skoglund A, Sunzel B, Lerner UH. Comparison of three test methods used for the diagnosis of candidiasis. Scandinavian Journal of Dental Research 1994;102(5):295-8.

52. Erkose G, Erturan Z. Oral Candida colonization of human

immunodeficiency virus infected subjects in Turkey and its relation with viral load and CD4+ T-lymphocyte count. Mycoses

2007;50(6):485-90.

53. Leon C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, et al. A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization.[see comment]. Critical Care Medicine 2006;34(3):730-7.

54. Suliman ME, Stenvinkel P, Barany P, Heimburger O, Anderstam B, Lindholm B. Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus. American Journal of Kidney Diseases 2003;41(3 Suppl 1):S89-95.

55. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Effects of nosocomial candidemia on outcomes of critically ill patients.

American Journal of Medicine 2002;113(6):480-5.

56. Pelz RK, Hendrix CW, Swoboda SM, Diener-West M, Merz WG, Hammond J, et al. Double-blind placebo-controlled trial of

fluconazole to prevent candidal infections in critically ill surgical patients. Annals of Surgery 2001;233(4):542-8.

57. Petri MG, Konig J, Moecke HP, Gramm HJ, Barkow H, Kujath P, et al. Epidemiology of invasive mycosis in ICU patients: a

prospective multicenter study in 435 non-neutropenic patients.

Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research. Intensive Care Medicine

1997;23(3):317-25.

58. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clinical Microbiology Reviews 2007;20(1):133-63.

59. Wong PN, Lo KY, Tong GM, Chan SF, Lo MW, Mak SK, et al.

Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD. Peritoneal Dialysis International 2007;27(5):531-6.

60. Tetta C, Biasioli S, Schiavon R, Inguaggiato P, David S, Panichi V, et al. An overview of haemodialysis and oxidant stress. Blood Purification 1999;17(2-3):118-26.

61. Korsrud FR, Brandtzaeg P. Quantitative immunohistochemistry of immunoglobulin- and J-chain-producing cells in human parotid and submandibular salivary glands. Immunology 1980;39:129-40.

62. Djoba Siawaya JF, Roberts T , Babb C , Black G , Golakai HJ, Stanley K , et al. An evaluation of commercial fluorescent bead-based luminex cytokine assays. PloS ONE 2008;Jul 2;3:e2535.

63. Eliasson L, Carlen A, Laine M, Birkhed D. Minor gland and whole saliva in postmenopausal women using a low potency oestrogen (oestriol). Archives of Oral Biology 2003 Jul;48(7):511-7.

64. Bayraktar G, Kazancioglu R, Bozfakioglu S, Ecder T, Yildiz A, Ark E. Stimulated salivary flow rate in chronic hemodialysis patients. Nephron 2002;91:210-4.

65. Barone F, Bombardieri M, Rosado MM, Morgan PR, Challacombe SJ, De Vita S, et al. CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: association with reactive and malignant areas of

lymphoid organization. Journal of Immunology 2008;180:5130-40.

66. Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, et al. IL-10, IL-6, and TNF-alpha: central factors in

the altered cytokine network of uremia--the good, the bad, and the ugly. Kidney International 2005;67(4):1216-33.

67. Johansson I, Ericson T, Steen L. Studies of the effect of diet on saliva secretion and caries development: the effect of fasting on saliva composition of female subjects. Journal of Nutrition 1984;114:2010-20.

68. Cederholm T, Persson M, Andersson P, Stenvinkel P, Nordfors L, Madden J, et al. Polymorphisms in cytokine genes influence long-term survival differently in elderly male and female patients.

Journal of Internal Medicine 2007;262:215-23.

69. Fletcher PD, Scopp IW, Hersh RA. Oral manifestations of

secondary hyperparathyroidism related to long-term hemodialysis therapy. Oral Surgery, Oral Medicine, Oral Pathology

1977;43:218-26.

70. Collins AR. The comet assay for DNA damage and repair:

principles, applications, and limitations. Mol Biotechnol 2004 Mar;26(3):249-61.

71. Stopper H, Boullay F, Heidland A, Vienken J, Bahner U. Comet-assay analysis identifies genomic damage in lymphocytes of uremic patients. American Journal of Kidney Diseases 2001 Aug;38(2):296-301.

72. Stopper H, Meysen T, Bockenforde A, Bahner U, Heidland A, Vamvakas S. Increased genomic damage in lymphocytes of patients before and after long-term maintenance hemodialysis therapy. American Journal of Kidney Diseases 1999

Sep;34(3):433-7.

73. Vanholder R, De Vriese A, Lameire N. The role of dialyzer biocompatibility in acute renal failure. Blood Purification 2000;18(1):1-12.

74. Ward RA, McLeish KR. Oxidant stress in hemodialysis patients:

what are the determining factors? Artif Organs 2003 Mar;27(3):230-6.

75. Ward RA, Ouseph R, McLeish KR. Effects of high-flux hemodialysis on oxidant stress. Kidney International 2003 Jan;63(1):353-9.

14 ORIGINAL PAPER

Related documents